Net Income

With a massive 200-mile range and a 550 lb payload, the new Tour 2.0 e-trike is engineered to be a powerful, practical car replacement.

Millions of parasitic wasps are California's front line against a disease threatening its $3.4B citrus industry. The real battle may be in your backyard.

As TI preps its Q1 2026 earnings call, all eyes are on its performance as an indicator for the industrial, auto, and broader semiconductor sectors.

San Diego's Origin Health unveils a new site and opens registration for its charity golf event, funding vital healthcare for local veterans and first responders.

With a massive profit jump, Vancity doubles down on community investment and branch expansion, challenging the Canadian banking industry's current trends.

Marking 40 years, NYC's Javits Center unveils its 'Javits on the Hudson' rebrand, highlighting its evolution into a sustainable, civic, and economic hub.

Stéphan Morency, a veteran of sustainable finance, will lead the newly combined Fondaction-Bâtirente entity, signaling a new era of impact-driven growth.

Amid global uncertainty, Centri’s exclusive NYC conference connects capital with 70+ high-growth firms in AI, fintech, and life sciences.

The investment firm reports a 213% revenue surge after a major acquisition, but a 'going concern' note raises questions about its financial footing.

A new all-in-one platform for financial advisors launches for free, but its model funded by asset managers raises questions about the true cost of 'free'.

A strategic partnership between Japan's Sojitz and FIDEM Energy aims to accelerate renewable natural gas production with a planned billion-dollar deployment.

Delcath Systems is set to showcase its innovative HEPZATO KIT at SIR 2026, signaling growing adoption and a pivotal moment for its targeted cancer therapy.

The tech firm posts impressive growth from defense and EV sectors, but a 'going concern' notice in its annual report reveals significant liquidity challenges.

With its pure-play chemical transition complete, Ascent adds two heavyweights to its board, signaling an aggressive new phase of growth and M&A.

Fed Governor Michael Barr's keynote at EMERGE 2026 signals a new regulatory focus on AI, data, and the economic realities facing American households.

With a key data readout looming for its chronic cough drug, Nocion adds a renowned dealmaker to its board, fueling speculation of a potential acquisition.

With a unique drug that preserves muscle while shedding fat, a newly fortified biotech is set to challenge the titans of the weight-loss market.

With the appointment of Stephen Gilderdale, Senzing signals its ambition to dominate the critical data trust layer for a new generation of autonomous AI.

A new CMS pilot program allows CBD for Medicare patients at no cost, sparking a race among suppliers like High Tide's NuLeaf Naturals to enter the market.

Canals' new end-to-end AI platform promises radical efficiency for distributors. But what are the real-world impacts on jobs, data, and integration?